Tamura, Kazuo http://orcid.org/0000-0002-2720-9774
Nukiwa, Toshihiro
Gemma, Akihiko
Yamamoto, Nobuyuki
Mizushima, Masaya
Ochai, Kaori
Ikeda, Rie
Azuma, Hisaya
Nakanishi, Yoichi
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 20 November 2018
Accepted: 27 March 2019
First Online: 5 April 2019
Change Date: 25 June 2019
Change Type: Correction
Change Details: The original article can be found online.
Compliance with ethical standards
:
: KT has received honoraria from Eisai, Ono Pharmaceutical, and Kyowa Hakko Kirin, and fees for promotional materials from Ono Pharmaceutical. AG and NY have received honoraria and research funding from Boehringer Ingelheim. YN has received honoraria from Boehringer Ingelheim. MM, RI, and HA are employees of Nippon Boehringer Ingelheim. KO is an employee of EPS Corporation. TN has nothing to disclose.
: To ensure independent interpretation of clinical study results, Boehringer Ingelheim grants all external authors access to all relevant material, including participant-level clinical study data, and relevant material as needed by them to fulfill their role and obligations as authors under the ICMJE criteria. Furthermore, clinical study documents (e.g. study report, study protocol, statistical analysis plan) and participant clinical study data are available to be shared after publication of the primary manuscript in a peer-reviewed journal and if regulatory activities are complete and other criteria met per the BI Policy on Transparency and Publication of Clinical Study Data:ExternalRef removed. Prior to providing access, documents will be examined, and, if necessary, redacted and the data will be de-identified, to protect the personal data of study participants and personnel, and to respect the boundaries of the informed consent of the study participants. Clinical Study Reports and Related Clinical Documents can be requested via this link:ExternalRef removed. All such requests will be governed by a Document Sharing Agreement. Bona fide, qualified scientific and medical researchers may request access to de-identified, analyzable participant clinical study data with corresponding documentation describing the structure and content of the datasets. Upon approval, and governed by a Data Sharing Agreement, data are shared in a secured data-access system for a limited period of 1 year, which may be extended upon request. Researchers should useExternalRef removedto request access to study data.